Cancer Family
Benign Neoplasm
CI-CAN-00000006Explore in graph →
Non-malignant177 active trials8 evidence items
- NCIt
- C3677
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000006Explore in graph →
Clinical trials
1,122 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02753361 | Ultra-sounded Guided Regional Blockade for Lipoma Excision | completed | N/A | 50 | Suez Canal UniversityOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT01536834 | Safety & Performance Study of Verruca Treatment Device | completed | N/A | 35 | Reckitt Benckiser LLCINDUSTRY | 1 | Oct 11, 2017 | clinicaltrials |
| NCT02167919 |
| Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) |
| completed |
| N/A |
| 15 |
| University of North Carolina, Chapel HillOTHER |
| 1 |
| Sep 14, 2017 |
| clinicaltrials |
| NCT01152112 | HOME Study: Hysteroscopic Office Myomectomy Evaluation(HOME) | completed | N/A | 74 | Hologic, Inc.INDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT01369758 | MyoSure Hysteroscopic Tissue Removal System Registry Study | completed | N/A | 290 | Hologic, Inc.INDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT00891657 | Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy | completed | N/A | 15 | Integra LifeSciences CorporationINDUSTRY | 1 | Sep 7, 2017 | clinicaltrials |
| NCT02835391 | PerClot Compared to Usual Care in Gynaecology Procedures | completed | N/A | 90 | CryoLife EuropaINDUSTRY | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03092999 | Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) | completed | Phase 1 | 36 | BayerINDUSTRY | 1 | Aug 18, 2017 | clinicaltrials |
| NCT02371811 | Use of v Care in Abdominal Hysterectomy | completed | N/A | 60 | Ain Shams Maternity HospitalOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02748902 | Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | completed | Phase 1 | 16 | Neal D. Bhatia, MDOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT00332033 | Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) | completed | Phase 2 | 32 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01140360 | Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas(0908-09) | completed | Phase 1 / Phase 2 | 21 | Kent RobertsonOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01337258 | Economic Analyses of the REDUCE Trial | completed | — | 1 | GlaxoSmithKlineINDUSTRY | 0 | May 30, 2017 | clinicaltrials |
| NCT01946178 | Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids | completed | N/A | 73 | Mirabilis Medica, Inc.INDUSTRY | 1 | May 30, 2017 | clinicaltrials |
| NCT03169595 | Epithelioid Hemangioma of Bone And Soft Tissue(EE-META) | completed | — | 70 | Istituto Ortopedico RizzoliOTHER | 0 | May 30, 2017 | clinicaltrials |
| NCT01371513 | Korean Practice Patterns for Screening PCA(Prostate Cancer)(RESPECT) | completed | — | 1 | GlaxoSmithKlineINDUSTRY | 1 | May 22, 2017 | clinicaltrials |
| NCT00356031 | Bevacizumab and Radiation Therapy for Sarcomas | completed | Phase 2 | 20 | Massachusetts General HospitalOTHER | 1 | May 19, 2017 | clinicaltrials |
| NCT01275586 | Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas | completed | Early Phase 1 | 6 | Indiana UniversityOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01412489 | Intrauterine Adhesion Rate After Hysteroscopic Myomectomy and Application of HYALOBARRIER Gel(HYGEM) | completed | N/A | 189 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT01936493 | Biologic Predictors of Leiomyoma Treatment Outcomes | completed | — | 38 | Elizabeth A. StewartOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT01484873 | Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor | completed | Phase 2 | 10 | Vanderbilt University Medical CenterOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01881854 | Sleep Wake and Melatonin Pattern in Craniopharyngioma | completed | — | 30 | Rigshospitalet, DenmarkOTHER | 0 | Feb 23, 2017 | clinicaltrials |
| NCT02249052 | Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma | completed | Phase 2 | 19 | Gerut, Zachary, M.D.INDIV | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02145884 | Topical Timolol Gel for the Treatment of Infantile Hemangiomas | completed | Phase 2 | 26 | Rady Children's Hospital, San DiegoOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT02104323 | Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors(Endostatin) | completed | Phase 2 | 20 | Beijing Tiantan HospitalOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02635789 | Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) | completed | Phase 3 | 62 | NobelpharmaINDUSTRY | 1 | Feb 2, 2017 | clinicaltrials |
| NCT00375765 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | completed | Phase 4 | 40 | GlaxoSmithKlineINDUSTRY | 1 | Jan 19, 2017 | clinicaltrials |
| NCT02997787 | New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma | completed | — | 60 | Kayseri Education and Research HospitalOTHER_GOV | 0 | Dec 26, 2016 | clinicaltrials |
| NCT02996747 | Low Grade Chondrosarcoma Versus Enchondroma(CONDRO1) | completed | — | 102 | Istituto Ortopedico RizzoliOTHER | 0 | Dec 22, 2016 | clinicaltrials |
| NCT02150213 | Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 | completed | Phase 2 | 59 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 5, 2016 | clinicaltrials |
| NCT01852734 | Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives | completed | N/A | 52 | Odense University HospitalOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT02465814 | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids(ASTEROID 2) | completed | Phase 2 | 120 | BayerINDUSTRY | 16 | Nov 22, 2016 | clinicaltrials |
| NCT01388907 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | completed | Phase 4 | 61 | Medtronic - MITGINDUSTRY | 1 | Nov 17, 2016 | clinicaltrials |
| NCT02963896 | Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma(ITG) | completed | N/A | 20 | University Hospital, MotolOTHER | 0 | Nov 15, 2016 | clinicaltrials |
| NCT01767363 | WEUSKOP5723: Prostate Cancer Study | completed | — | 1 | GlaxoSmithKlineINDUSTRY | 0 | Nov 9, 2016 | clinicaltrials |
| NCT01999270 | Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors | completed | Phase 1 | 6 | Washington University School of MedicineOTHER | 1 | Oct 21, 2016 | clinicaltrials |
| NCT01613313 | A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma | completed | Phase 2 | 14 | Zachary GerutINDIV | 1 | Oct 6, 2016 | clinicaltrials |
| NCT01592903 | Somatic Stem Cells in Leiomyomas? | completed | — | 16 | IgenomixINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02334930 | Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors(PEC-Hem) | completed | — | 13 | University Hospital, BordeauxOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT02846467 | Information Improvement for Surgical Patients Through Portable Video Media | completed | N/A | 193 | Hospital Universitario Puerto RealOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02063295 | An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury | completed | Phase 2 | 14 | Zafgen, Inc.INDUSTRY | 2 | Jul 18, 2016 | clinicaltrials |
| NCT02819609 | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | completed | — | 12,234 | Quintiles, Inc.INDUSTRY | 0 | Jun 30, 2016 | clinicaltrials |
| NCT00603694 | Hippocampal Radiation Exposure and Memory | completed | — | 1 | University Health Network, TorontoOTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT02298270 | Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype | completed | N/A | 65 | Massachusetts General HospitalOTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00973739 | Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors | completed | Phase 2 | 21 | NYU Langone HealthOTHER | 1 | Mar 22, 2016 | clinicaltrials |
| NCT02483455 | ALC-919 For The Treatment Of Common Warts | completed | Phase 2 | 21 | Veloce BioPharma LLCINDUSTRY | 1 | Mar 9, 2016 | clinicaltrials |
| NCT01985113 | Correlation Research of Thioredoxin Reductase in Lung Cancer(TRCRLC) | completed | — | 165 | Hunan Province Tumor HospitalOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00887809 | Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes | completed | Phase 2 | 47 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 25, 2016 | clinicaltrials |
| NCT01156857 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIII) | completed | Phase 3 | 209 | PregLem SAINDUSTRY | 4 | Jan 15, 2016 | clinicaltrials |
| NCT00608842 | Phase 2 Study for the Treatment of Superficial Lipomas | completed | Phase 2 | 62 | Kythera BiopharmaceuticalsINDUSTRY | 1 | Jan 14, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Oct 19, 2017source: clinicaltrials